Injective (INJ) is currently priced at $3.08, reflecting a slight decline of 0.36% over the last 24 hours. The daily trading range remains narrow, with a high of $3.16 and a low of $3.06, indicating a period of consolidation.

Volume stands at 51,390,626, representing 16.69% of its market cap, which suggests moderate trading activity. The hourly moving averages reveal a bearish trend, with the 8 SMA and 13 SMA both showing negative momentum, while the longer-term SMAs (55 and 144) indicate a slight bullish sentiment.

The 1-hour RSI is at 41, signaling a potential oversold condition, but still within neutral territory. In contrast, the 7-day RSI is at 49, reflecting a balanced market sentiment but indicating a downward trend with a 7-day price change of -3.61%.

Over the past 14 days, INJ has experienced a price decrease of 3.84%, and a more substantial decline of 16.39% over the last 30 days. This longer-term downtrend, coupled with the proximity to critical support levels, suggests caution among traders.

Injective's all-time high of $52.62, reached on March 14, 2024, provides a stark contrast to its current valuation, emphasizing a significant retracement. The market appears to be digesting previous gains, and the recent price behavior indicates potential for a short-term rebound.

Considering the technical indicators and the recent price action, I recommend a Hold rating for Injective (INJ). The current price level reflects a consolidation phase, and potential buyers may want to observe for a confirmation of upward movement before entering the market.